Marfan syndrome in the third Millennium

被引:61
作者
Collod-Béroud, G
Boileau, C
机构
[1] Hop Necker Enfants Malad, INSERM, U383, Clin Maurice LAMY, F-75743 Paris 15, France
[2] Hop Ambroise Pare, Lab Biochim Hormonol & Genet Mol, F-92104 Boulogne, France
关键词
Marfan syndrome; MFS; FBN1; fibrillin-1; review; structure;
D O I
10.1038/sj.ejhg.5200876
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Marfan syndrome (MFS) is a prominent member of heritable disorders of connective tissue with manifestations involving primarily the skeletal, ocular and cardiovascular systems but also and less systematically investigated the lung, skin and integument, and dura. Over the last two decades, a considerable amount of clinical, molecular and protein data had accumulated. In combination with the study of natural and transgenic animal models, this new information provides greater insight into the pathogenic mechanisms underlying not only the pleiotropic manifestations of MFS but also the important degree of clinical variability (age of onset and severity) observed between patients. The following aspects will be described in this review: the structure and function of fibrillin-1; the fibrillin proteins; mutations in the FBN1 gene and pathogenic mechanisms; animal models. Finally, the currently available laboratory diagnostic tests and their limits will be discussed.
引用
收藏
页码:673 / 681
页数:9
相关论文
共 66 条
[21]   MARFAN-SYNDROME CAUSED BY A RECURRENT DENOVO MISSENSE MUTATION IN THE FIBRILLIN GENE [J].
DIETZ, HC ;
CUTTING, GR ;
PYERITZ, RE ;
MASLEN, CL ;
SAKAI, LY ;
CORSON, GM ;
PUFFENBERGER, EG ;
HAMOSH, A ;
NANTHAKUMAR, EJ ;
CURRISTIN, SM ;
STETTEN, G ;
MEYERS, DA ;
FRANCOMANO, CA .
NATURE, 1991, 352 (6333) :337-339
[22]   Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4 [J].
Giltay, R ;
Timpl, R ;
Kostka, G .
MATRIX BIOLOGY, 1999, 18 (05) :469-480
[23]  
GLANVILLE RW, 1994, J BIOL CHEM, V269, P26630
[24]  
GODFREY M, 1993, AM J HUM GENET, V53, P472
[25]  
GODFREY M, 1995, AM J PATHOL, V146, P1414
[26]   Fibrillin: from domain structure to supramolecular assembly [J].
Handford, PA ;
Downing, AK ;
Reinhardt, DP ;
Sakai, LY .
MATRIX BIOLOGY, 2000, 19 (06) :457-470
[27]   IMMUNOHISTOLOGIC ABNORMALITIES OF THE MICROFIBRILLAR-FIBER SYSTEM IN THE MARFAN-SYNDROME [J].
HOLLISTER, DW ;
GODFREY, M ;
SAKAI, LY ;
PYERITZ, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (03) :152-159
[28]   Structure and chromosomal assignment of the human S1-5 gene (FBNL) that is highly homologous to fibrillin [J].
Ikegawa, S ;
Toda, T ;
Okui, K ;
Nakamura, Y .
GENOMICS, 1996, 35 (03) :590-592
[29]   Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3) [J].
Jaubert, J ;
Jaubert, F ;
Martin, N ;
Washburn, LL ;
Lee, BK ;
Eicher, EM ;
Guénet, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) :10278-10283
[30]   2 MUTATIONS IN MARFAN-SYNDROME RESULTING IN TRUNCATED FIBRILLIN POLYPEPTIDES [J].
KAINULAINEN, K ;
SAKAI, LY ;
CHILD, A ;
POPE, FM ;
PUHAKKA, L ;
RYHANEN, L ;
PALOTIE, A ;
KAITILA, I ;
PELTONEN, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) :5917-5921